Coverage / JAZZ / Trade Card

JAZZ

Jazz Pharmaceuticals PLC

BUY Analysis generated 2026-10-04 Market data as of 2026-11-12 Market data 3 days old USD 240.37 Healthcare - BiotechnologyAWAIT ENTRY
ACTIONABLEMethodology gates passed
68

Position levels

Currenttoday
USD 240.37
Buy <=wait / entry
USD 181.33
Trim >=take some off
USD 248.00
Thesis breakA material revenue or earnings miss against 2026 guidance, a regulatory or comme...
-

Scenario-weighted conviction

ProbabilityScoreContribution
Bull case37%100 / 10037.0
Base case47%62 / 10029.1
Bear case16%10 / 1001.6
Weighted conviction68 / 100 - BUY

Top risks

  • M&A activity: Completed $1.3B acquisition of Actio Biosciences in September 2026
  • Strategic licensing deal: AbCellera antibody collaboration worth up to $876 million
  • Earnings performance: Record total revenues of $4.3 billion in 2025 with Q2 2026 revenue of $1.21B
Read full report →

Research is for informational purposes only. Not financial advice. All analysis reflects the date of publication.

\n